Share-based Compensation Plans (Tables)

12 Months Ended

Dec. 31, 2013

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Share-based Compensation Expense

	2013	2012	2011
	$’M	$’M	$’M
	____________	____________	____________
Cost of product sales	4.4	6.3	8.8
Research and development	22.8	25.8	21.8
Selling, general and administrative	46.9	55.0	45.1
Reorganization costs	3.3	-	-
	____________	____________	____________
Total	77.4	87.1	75.7
Less tax	(18.1)	(23.8)	(23.6)
	____________	____________	____________
	59.3	63.3	52.1
	____________	____________	____________

Share-based Awards Outstanding

	Compensation type	Number of awards*	Expiration period from date of issue	Vesting period
	____________	____________	____________	____________
Portfolio Share Plan - Part A	SARs	14,083,748	5 - 7 years	3 years cliff or graded vesting, subject to market or performance criteria for Executive Directors only
Sharesave Scheme	Stock options	243,783	6 months after vesting	3 or 5 years
Stock Purchase Plan	Stock options	568,828	On vesting date	1 to 5 years
Legacy Plans	Stock options	132,823	7 to 10 years	3-10 years, subject to market or performance criteria
		__________________
Stock-settled SARs and stock options		15,029,182
		__________________
Portfolio Share Plan - Part B	Performance share awards	2,701,299	3 years	3 years cliff or graded vesting, subject to market or performance criteria for Executive Directors only
		__________________
Performance share awards		2,701,299
		__________________

Summary of Status of Stock Appreciation Rights and Stock Options

	Weighted average exercise price
Year to December 31, 2013	£	Number of	Intrinsic Value
		shares*	£’ M
	_______________	_______________	_______________
Outstanding as at beginning of period	16.66	18,536,947
Granted	20.05	6,914,026
Exercised	22.09	(8,302,740)
Forfeited	18.30	(2,119,051)
	_______________	_______________	________________
Outstanding as at end of period	18.88	15,029,182	143.9
	_______________	_______________	________________
Exercisable as at end of period	15.67	3,670,446	46.9
	_______________	_______________	________________

Schedule of Stock Appreciation Rights and Stock Options Outstanding, by Exercise Price Range

Number of awards outstanding*	Exercise prices	Weighted Average remaining contractual term (Years)	Weighted average exercise price of awards outstanding	Number of awards exercisable	Weighted average exercise price of awards exercisable
	£		£		£
________________	______________	__________	_______________	_____________	_____________
104,658	3.38-7.00	1.1	5.56	104,658	5.56
810,822	7.01-14.00	2.8	11.27	804,402	11.25
14,113,702	14.01-28.00	4.9	18.07	2,761,386	17.34
________________				_____________
15,029,182				3,670,446
________________				_____________

Schedule of Performance Share Awards

Performance share awards	Number of shares*	Aggregate intrinsic value £’M	Weighted average remaining life
	_______________	_______________	_______________
Outstanding as at beginning of period	3,518,138
Granted	1,508,631
Exercised	(1,826,648)
Forfeited	(498,822)
	_______________
Outstanding as at end of period	2,701,299	76.9	5.5
	_______________	_______________	________________
Exercisable as at end of period	-	N/A	N/A
	_______________	_______________	_______________

Schedule of Share-based Payment Award, Valuation Assumptions

Period ended December 31,	2013	2012	2011
	______________	______________	______________
Risk-free interest rate1	0.1-0.9%	0.2-1%	0.1-2.5%
Expected dividend yield	0.4-0.6%	0-0.6%	0-0.5%
Expected life	1-4 years	1-4 years	1-5 years
Volatility	23-26%	24-32%	19-33%
Forfeiture rate	5-9%	5-7%	5-7%